Centene Corp (CNC) · Sep 15, 2026 · Guidance
Guidance reaffirmed — GAAP EPS >$3.11; adjusted EPS >$4.80
Centene repeats its 2026 EPS floors at an investor conference, confirming the recovery plan but adding no new financial information.
Centene is in a profitability-recovery phase after severe Marketplace and Medicaid pressure, using better pricing, risk-adjustment revenue, Medicaid rate actions and Medicare PDP growth to rebuild earnings power. Its second-quarter update had already lifted 2026 adjusted EPS guidance above $4.80, while acknowledging that roughly $0.50 of the improvement came from non-recurring Medicare and Commercial items.
This filing adds confirmation, not information. Management is simply repeating the existing full-year floors: The same adjusted EPS guidance had already been reaffirmed publicly on August 17, 2026.
| Measure | Reaffirmed 2026 guidance |
|---|---|
| GAAP diluted EPS | >$3.11 |
| Adjusted diluted EPS | >$4.80 |
The recovery plan remains intact, but this is not another upgrade. The filing provides no new operating metrics, no new earnings data and no additional detail on whether medical-cost trends or membership are tracking better than the July outlook. It therefore does not materially change the standing business story.
Bottom line: Centene is holding its recovery targets, but this 8-K is a scheduled investor-relations confirmation rather than a fresh business development. Under the event-driven lens, it is neutral and already known.alk
Healthcare Summit presentation, September 16
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!